Delivery Order SPE2DB22D1017-SPE2DB25FG8PC
- Not listed
- The Defense Logistics Agency awarded a $21,325.14 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Tagrisso 80 mg, a prescription oncology medication used to treat certain lung cancers. This firm fixed price delivery order, awarded on July 18, 2025, with an ultimate completion date of August 8, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract carries no set-aside designation, indicating it was...
- The Defense Logistics Agency awarded a delivery order valued at approximately $32,000 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of August 15, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Tagrisso 80 mg tablets (30-count) valued at $21,325.14. This firm fixed-price delivery order, with an ultimate completion date of August 11, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, and the place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $31,987.71 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) on July 23, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was awarded without a set-aside designation through open competition, reflecting the contractor's capability to meet federal procurement standards. The contract will be performed at AmerisourceBergen's corporate office...
- This is a $42,607.28 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tagrisso 80 mg tablets, a cancer medication, with a period of performance through July 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) with a ceiling value of $31,987.71. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating that AmerisourceBergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,641.07 firm fixed-price delivery order is for TAGRISSO 40 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on July 23, 2025, for TAGRISSO 40 mg tablets (30-count packages). The contract, valued at $10,641.07, is scheduled for completion by August 13, 2025, and represents a non-competitive set-aside delivery order placed against the company's existing Indefinite Delivery Contract with DLA. This award falls under...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,538.79 firm-fixed-price contract is for the supply of TAGRISSO 80 MG TABLET 30S, a specialty pharmaceutical product. The contract has an ultimate completion date of September 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count unit) with a ceiling value of $10,662.57. This firm fixed-price delivery order, awarded on July 30, 2025, represents a non-set-aside competitive award with an ultimate completion date of August 20, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG8PCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,641.07 to AmerisourceBergen Drug Corp for 30 tablets of TAGRISSO 40 MG, a targeted cancer therapy medication. This firm fixed price delivery order, issued on July 30, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 through December 2026. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. No set-aside designation was applied to this competitive award. This delivery order is part of AmerisourceBergen Drug Corp's extensive pharmaceutical supply portfolio supporting military and veteran healthcare systems. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains a comprehensive contract vehicle with DLA for supplying brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs globally. The company's demonstrated capability to fulfill federal medical supply requirements through open competition is reflected in its consistent award of competitively-bid delivery orders with firm fixed pricing structures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 7/30/25 |